With more than 11 years of experience, Michael Gleason counsels clients on antitrust matters before US and international enforcement agencies, including transactions and government investigations, as well as antitrust litigation. He has been involved in some of the most significant transactions to come before the antitrust agencies, particularly in the healthcare industry.
Michael has represented a variety of clients before the US DOJ, FTC and state, and international antitrust enforcers, and has extensive experience in a range of industries, including healthcare (providers and payers), pharmaceuticals, medical devices, software, chemicals, mining, defence and food products, among others. His transactional work includes counselling clients at every stage of a deal, including pre-merger planning, regulatory filings, investigations, litigation, as well as post-closing investigations. Michael also advises clients on a variety of antitrust issues, including competitor and vertical collaborations, information sharing, distribution arrangements and single-firm conduct.
Michael is a member of the ABA’s Section of Antitrust Law and the Antitrust Practice Group of the American Health Lawyers Association. Michael is the vice chair of the ABA Section of Antitrust Law’s Mergers and Acquisitions Committee, and served as co-editor of the recently published Health Care Mergers and Acquisitions Handbook.